Oral antioxidant therapy for prevention and treatment of preeclampsia: Meta-analysis of randomized controlled trials
- PMID: 30111493
- DOI: 10.1016/j.numecd.2018.06.002
Oral antioxidant therapy for prevention and treatment of preeclampsia: Meta-analysis of randomized controlled trials
Abstract
Aims: To determine whether oral antioxidant therapies, of various types and doses, are able to prevent or treat women with preeclampsia.
Data synthesis: The following databases were searched: MEDLINE, CENTRAL, LILACS, and Web of Science. Inclusion criteria were: a) randomized clinical trials; b) oral antioxidant supplementation; c) study in pregnant women; d) control group, treated or not with placebo. Papers were excluded if they evaluated antioxidant nutrient supplementation associated with other non-antioxidant therapies. Data were extracted and the risk of bias of each study was assessed. Heterogeneity was analyzed using the Cochran Q test, and I2 statistics and pre-specified sensitivity analyses were performed. Meta-analyses were conducted on prevention and treatment studies, separately. The primary outcome was the incidence of preeclampsia in prevention trials, and of perinatal death in treatment trials. Twenty-nine studies were included in the analysis, 19 for prevention and 10 for treatment. The antioxidants used in these studies were vitamins C and E, selenium, l-arginine, allicin, lycopene and coenzyme Q10, none of which showed beneficial effects on the prevention of preeclampsia (RR: 0.89, CI 95%: [0.79-1.02], P = 0.09; I2 = 39%, P = 0.04) and other outcomes. The antioxidants used in the treatment studies were vitamins C and E, N-acetylcysteine, l-arginine, and resveratrol. A beneficial effect was found in intrauterine growth restriction.
Conclusions: Antioxidant therapy had no effects in the prevention of preeclampsia but did show beneficial effects in intrauterine growth restriction, when used in the treatment of this condition.
Keywords: Antioxidant; Oral administration; Preeclampsia; Pregnant women.
Copyright © 2018 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.
Similar articles
-
The role played by oral antioxidant therapies in preventing and treating preeclampsia: An updated meta-analysis.Nutr Metab Cardiovasc Dis. 2023 Jul;33(7):1277-1292. doi: 10.1016/j.numecd.2023.02.003. Epub 2023 Feb 25. Nutr Metab Cardiovasc Dis. 2023. PMID: 37246073
-
Acetylsalicylic acid for the prevention of preeclampsia and intra-uterine growth restriction in women with abnormal uterine artery Doppler: a systematic review and meta-analysis.J Obstet Gynaecol Can. 2009 Sep;31(9):818-826. doi: 10.1016/S1701-2163(16)34300-6. J Obstet Gynaecol Can. 2009. PMID: 19941706 Review.
-
The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis.Am J Obstet Gynecol. 2017 Feb;216(2):110-120.e6. doi: 10.1016/j.ajog.2016.09.076. Epub 2016 Sep 15. Am J Obstet Gynecol. 2017. PMID: 27640943 Review.
-
Low-Dose Aspirin for the Prevention of Morbidity and Mortality From Preeclampsia: A Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 Apr. Report No.: 14-05207-EF-1. Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 Apr. Report No.: 14-05207-EF-1. PMID: 24783270 Free Books & Documents. Review.
-
Vitamin E supplementation in pregnancy.Cochrane Database Syst Rev. 2005 Apr 18;(2):CD004069. doi: 10.1002/14651858.CD004069.pub2. Cochrane Database Syst Rev. 2005. Update in: Cochrane Database Syst Rev. 2015 Sep 07;(9):CD004069. doi: 10.1002/14651858.CD004069.pub3. PMID: 15846695 Updated. Review.
Cited by
-
Genetically predicted circulating concentrations of micronutrients and risk of hypertensive disorders of pregnancy: a Mendelian randomization study.Arch Gynecol Obstet. 2024 Aug;310(2):1019-1025. doi: 10.1007/s00404-023-07331-y. Epub 2024 Jan 9. Arch Gynecol Obstet. 2024. PMID: 38194093
-
VASCULAR AND RENAL MECHANISMS OF PREECLAMPSIA.Curr Opin Physiol. 2023 Jun;33:100655. doi: 10.1016/j.cophys.2023.100655. Epub 2023 Mar 2. Curr Opin Physiol. 2023. PMID: 37009057 Free PMC article.
-
Oleuropein Attenuates Oxidative Stress in Human Trophoblast Cells.Antioxidants (Basel). 2023 Jan 14;12(1):197. doi: 10.3390/antiox12010197. Antioxidants (Basel). 2023. PMID: 36671060 Free PMC article.
-
[Glucose Metabolism-Derived Nicotinamide Adenine Dinucleotide Phosphate in Late-Onset Preeclampsia Placenta Tissue and Its Correlation with Oxidative Stress].Sichuan Da Xue Xue Bao Yi Xue Ban. 2022 Nov;53(6):1028-1032. doi: 10.12182/20221160212. Sichuan Da Xue Xue Bao Yi Xue Ban. 2022. PMID: 36443047 Free PMC article. Chinese.
-
Endothelial dysfunction in preterm infants: The hidden legacy of uteroplacental pathologies.Front Pediatr. 2022 Nov 4;10:1041919. doi: 10.3389/fped.2022.1041919. eCollection 2022. Front Pediatr. 2022. PMID: 36405831 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical